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Introduction 
Burns are serious, complex injuries that frequently lead 
to disability and death. Consequently, their diagnosis 
and treatment requires a special approach [1, 2]. Ac-
cording to the American Burn Association, 450,000 
people receive medical attention for burn wounds, with 
40,000 requiring hospitalization and 3,400 deaths at-
tributed to burn wounds [3].  
Significant successes in the treatment of deep burns 
became possible thanks to active surgical tactics in the 
treatment of severe burns [4-6]. 
The essence of the operative treatment of deep burns 
lies in one way or another to compensate for the defect 
of the skin, resulting from their necrosis. The most com-
mon method of restoring the integrity of the skin is free 
plastic skin. Plastic closure of a burn wound is preceded 
by its preparation, which consists in cleansing the 
wound from necrotic tissues and forming a bed condu-
cive to engraftment. The preparation of burn wounds for 
autodermoplasty can be carried out at different times, 
using different methods, characterized by greater or 
lesser “aggressiveness”. In all cases, the final stage is 
the closure of the wound surface [7, 8]. 
The aim of the work is to improve the results of early 
necrectomy with autodermoplasty in burned patients 
with the use of local hemostatic drug “Geprocel”. 
Materials  
The work is based on the analysis of the treatment re-
sults of 35 patients with burn trauma (10 women and 25 
men) aged 15 to 55 years who were treated in the burn 
department of Republican Scientific Centre of Urgent 
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Medical Aid (RSCUMA) between 2017 and 2018.  
The causes of the burns were as follows: flame - 21 cas-
es; scalds – 8 cases; and contact burns 6 cases. 
The total area of the lesion in patients ranged from 5 to 
20% of the body surface, and a deep burn of III B – IV 
degree to 10%. 
All patients underwent early necrectomy to healthy tis-
sues with the appearance of capillary hemorrhage with 
simultaneous autodermoplasty. Hemostasis was carried 
out with hemostatic powder from cellulose derivatives 
with the preparation Geprocel 10 mg of powder once a 
day for 3 days. 
Methods and Results 
The clinical evaluation included the following criteria: 
the number and nature of the discharge; bleeding of 
wounds; timing of epithelialization of donor sites, trans-
planted autodermotransplants; full epithelialization; 
severity of wound pain. 
Surgical intervention for 35 patients with deep burns 
consisted in the use of the hemostatic preparation Ge-
procel to stop bleeding after excision of necrotic skin 
and subcutaneous structures. 
Our researches have shown that early surgical 
necroectomy and the taking of split autotransplants from 
donor sites is accompanied by blood loss (6-10 ml of 
blood over an area of 100 cm2), and immediately after 
the application of the hemostatic Geprocel powder, the 
bleeding completely stops and the wound surface takes 
on a brilliant appearance due to the adhered to her film. 
Pain was insignificant. When the wound defect was 
closed by donor autografts, good adhesion of the skin 
graft to the underlying wound was noted. 
When viewed on the next day, signs of skin graft necro-
sis were not observed. The donor's wound is also clean; 
there are no signs of infection or pain. 
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On the 3rd day after the operation, the patients had a 
positive dynamics of skin graft healing. Discharge from 
the wound was not observed. There are no signs of in-
flammation and infection in the donor site. 
On the 7th day after the skin transplantation there is an 
almost complete engraftment of the skin graft, the su-
ture line in the form of a clear thin line, with no signs of 
reddening or infiltration. The skin graft is soft, elastic, 
pale pink. Signs of infection are not marked. The donor 
site was completely epithelized, there remained a thin 
elastic scar without signs of hypertrophy and inflamma-
tion, painless. 
On the 12th day, complete autotransplant of the skin 
took place, with complete restoration of the defect with 
a slight contraction of the defect area. 
Thus, in patients, the use of the film form of the hemo-
static drug “Geprocel” after necrectomy with subse-
quent autodermoplasty in all cases contributed to the 
complete healing of donor sites for 7 days, and the com-
plete engraftment of the skin autotransplant with full 
recovery of the defect by 12 days after surgery (Table 
1). 
Table 1. Comparative analysis of the present and 
future treatment results of patients with different 
kinds of burns 
Note: * – P<0,05on comparison 
Discussion  
Thermal damages are a serious medical, social and eco-
nomic problem. With the development of heavy indus-
try and the chemical industry, as well as the widespread 
use of electrical energy in everyday life and industry 
contribute to a significant increase in burn injuries. 
Historically, there are two main areas of surgical treat-
ment of burned ones: 1) autodermoplasty of granulating 
post-burn wounds after spontaneous rejection of necrot-
ic tissue or chemical necrectomy; 2) early surgical ne-
crectomy before the development of inflammation in the 
wound with subsequent autodermoplasty [9-11]. 
Independent rejection of dead tissue with deep burns 
leads to a complete cleansing of the wound surface after 
4-6 weeks. The long existence of burn scab prevents the 
implementation of autodermoplastic, contributes to the 
development of pyogenic microflora in the burn wound 
and the release of toxic substances. 
In this regard, it is clear the desire of doctors to acceler-
ate the rejection of necrotic tissue, suppress purulent 
infection in the wound and reduce the time of preopera-
tive preparation for skin grafting. 
Due to early surgical treatment (removal of a burn scab 
in the first 3-7 days after injury with simultaneous or 
delayed autodermoplasty), there are opportunities to 
change the course of the burn disease and interrupt its 
course. The time taken to prepare burn wounds for auto-
dermoplasty, the time to restore the integrity of the skin, 
the duration of inpatient treatment, the number of infec-
tious complications and deaths are reduced. 
But early surgical necrectomy is quite a traumatic oper-
ation, and may be accompanied by abundant blood loss. 
According Musgrave M (2000) blood loss was at least 
250-300 ml with a wound surface of 10% According to 
other data, with early excision of dead tissue in an area 
of 100 cm2 leads to a loss of 76 ml of blood, and the 
removal of granulations in the same area – 64 ml [12].  
It should also be taken into account that the operation of 
autodermoplasty provides for the formation of extensive 
"donor" wound surfaces, often equal in area to burns. 
Given the operational risk associated with blood loss 
and pain impulses, an increase in the area of lost skin 
puts this type of surgery in a special place [13-14]. 
Therefore, local hemostatic therapy adequately carried 
out during the operation can prevent blood loss, thereby 
improving the results of treatment of this cohort of pa-
tients. 
Conclusions 
1) Use of the drug Geprocel during autodermoplasty 
after early necrectomy provides complete hemostasis 
and a reduction in the severity of wound pain.  
2) Local single application of the hemostatic prepara-
tion Gepotsel after an autodermoplasty to a wound 
after necrectomy contributes to the rapid adhesion of 
the graft ensures a swift and complete engraftment 
of skin grafts. 
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